5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.59%
Positive revenue growth while STERV.HE is negative. John Neff might see a notable competitive edge here.
179.92%
Positive gross profit growth while STERV.HE is negative. John Neff would see a clear operational edge over the competitor.
42.16%
EBIT growth below 50% of STERV.HE's 189.45%. Michael Burry would suspect deeper competitive or cost structure issues.
42.16%
Operating income growth under 50% of STERV.HE's 189.45%. Michael Burry would be concerned about deeper cost or sales issues.
-20.26%
Negative net income growth while STERV.HE stands at 172.26%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-21.30%
Negative EPS growth while STERV.HE is at 172.22%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-21.30%
Negative diluted EPS growth while STERV.HE is at 176.47%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.35%
Share reduction more than 1.5x STERV.HE's 3.61%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.35%
Slight or no buyback while STERV.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-157.58%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-329.13%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-26.92%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-26.92%
Negative 5Y CAGR while STERV.HE stands at 17.67%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-29.81%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-146.57%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-146.57%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-152.08%
Negative 3Y OCF/share CAGR while STERV.HE stands at 449.18%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
119.59%
Positive 10Y CAGR while STERV.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
119.59%
Below 50% of STERV.HE's 359.16%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-15.03%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.10%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.91%
AR growth well above STERV.HE's 34.05%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.35%
Inventory shrinking or stable vs. STERV.HE's 19.40%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
0.42%
Asset growth well under 50% of STERV.HE's 5.68%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-0.00%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
2.74%
Debt shrinking faster vs. STERV.HE's 11.52%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
0.85%
SG&A growth well above STERV.HE's 1.28%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.